XOMA Royalty (FRA:X0M1) E10: €-1.67 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:X0M1 XOMA Royalty Corp FRA:X0M1
41 GF Score
Price €35.20
GF Value €16.60
! 8 Warning Signs
View Full Analysis

What is XOMA Royalty E10?

XOMA Royalty FRA:X0M1 41 E10 is €-1.67 as of Mar. 2026. GuruFocus rates FRA:X0M1 with a GF Score™ of 41/100 and a GF Value™ of €16.60. The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

XOMA Royalty's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.147. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.67 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 32.80% per year. During the past 5 years, the average E10 Growth Rate was 30.00% per year. During the past 10 years, the average E10 Growth Rate was 27.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of XOMA Royalty was 33.90% per year. The lowest was 3.60% per year. And the median was 13.40% per year.

As of today (2026-07-21), XOMA Royalty's current stock price is €35.20. XOMA Royalty's E10 for the quarter that ended in Mar. 2026 was €-1.67. XOMA Royalty's Shiller PE Ratio of today is .


XOMA Royalty  (FRA:X0M1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


XOMA Royalty E10 Related Terms


XOMA Royalty E10 Historical Data

* Premium members only.

The historical data trend for XOMA Royalty's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XOMA Royalty E10 Chart

XOMA Royalty Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.59 -6.70 -3.28 -2.60 -1.77

XOMA Royalty Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.08 -1.55 -1.31 -1.77 -1.67

FRA:X0M1 vs CLYM, CTMX, ALLO: E10 Comparison

For the Biotechnology subindustry, XOMA Royalty's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XOMA Royalty Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XOMA Royalty's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where XOMA Royalty's Shiller PE Ratio falls into.


FRA:X0M1
41GF Score
XOMA Royalty Corp FRA:X0M1
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XOMA Royalty E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, XOMA Royalty's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.147/330.2130*330.2130
=0.147

Current CPI (Mar. 2026) = 330.2130.

XOMA Royalty Quarterly Data

per share eps CPI Adj_EPS
201606 -2.243 241.018 -3.073
201609 -1.853 241.428 -2.534
201612 -2.740 241.432 -3.748
201703 -2.216 243.801 -3.001
201706 0.018 244.955 0.024
201709 1.661 246.819 2.222
201712 -0.135 246.524 -0.181
201803 -0.373 249.554 -0.494
201806 -0.197 251.989 -0.258
201809 -0.471 252.439 -0.616
201812 -0.308 251.233 -0.405
201903 0.186 254.202 0.242
201906 -0.416 256.143 -0.536
201909 0.182 256.759 0.234
201912 -0.441 256.974 -0.567
202003 -0.443 258.115 -0.567
202006 -0.293 257.797 -0.375
202009 -0.085 260.280 -0.108
202012 1.085 260.474 1.375
202103 -0.588 264.877 -0.733
202106 -0.257 271.696 -0.312
202109 -0.434 274.310 -0.522
202112 1.478 278.802 1.751
202203 -0.291 287.504 -0.334
202206 -0.501 296.311 -0.558
202209 -0.485 296.808 -0.540
202212 -0.604 296.797 -0.672
202303 -0.915 301.836 -1.001
202306 -0.545 305.109 -0.590
202309 -0.562 307.789 -0.603
202312 -1.715 306.746 -1.846
202403 -0.791 312.332 -0.836
202406 0.780 314.175 0.820
202409 -1.433 315.301 -1.501
202412 -0.430 315.605 -0.450
202503 0.055 319.799 0.057
202506 0.381 322.561 0.390
202509 0.596 324.800 0.606
202512 0.222 324.054 0.226
202603 0.147 330.213 0.147

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-1.67 mean?
XOMA Royalty (FRA:X0M1) has a E10 of €-1.67 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on XOMA Royalty and its competitors.
Is XOMA Royalty's E10 too high?
XOMA Royalty's current E10 is €-1.67. Overall, XOMA Royalty has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does XOMA Royalty's E10 compare to CLYM and CTMX?
XOMA Royalty's E10 of €-1.67 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on XOMA Royalty and its competitors. XOMA Royalty's current E10 is €-1.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XOMA Royalty stock overvalued right now?
XOMA Royalty (FRA:X0M1) has a current E10 of €-1.67. The stock's GF Value™ is €16.60, compared to a current price of €35.20 — trading 112% above its estimated fair value. The current E10 is €-1.67. XOMA Royalty's overall GF Score™ is 41/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For XOMA Royalty (FRA:X0M1), the current E10 is €-1.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is XOMA Royalty (FRA:X0M1) Overvalued in 2026?

Based on GuruFocus' analysis, XOMA Royalty stock appears to be overvalued. The current stock price of €35.20 is trading 112% above its estimated GF Value™ of €16.60.

Key valuation signals for FRA:X0M1:

  • E10: €-1.67
  • GF Value™: €16.60 vs. price of €35.20 (112% above fair value)
  • GF Score™: 41/100 with 8 warning signs

No single metric tells the full story. See the FRA:X0M1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


XOMA Royalty Business Description

Address 2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.
41GF Score

Get the complete analysis for FRA:X0M1

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€35.20
Price
€16.60
GF Value